Nonlinear dobutamine pharmacokinetics in a pediatric population

Area of Science:

• Pharmacokinetics
• Pediatric Critical Care
• Drug Metabolism

Background:

• Dobutamine is a commonly used inotrope in pediatric critical care.
• Understanding dobutamine pharmacokinetics is crucial for optimizing its use.
• Previous models may not fully capture dobutamine's behavior in pediatric populations.

Purpose of the Study:

• To evaluate the suitability of a linear kinetic model for dobutamine clearance in pediatric patients.
• To investigate factors influencing dobutamine clearance, including patient demographics and co-administered drugs.

Main Methods:

• Prospective evaluation of 12 pediatric patients (2 days to 9 years) receiving continuous dobutamine infusions.
• Dobutamine infusion rates varied from 2 to 15 mcg/kg/min.
• Serum concentrations and clearance rates were measured and analyzed.

Main Results:

• Dobutamine serum concentrations ranged from 6.4 to 347 ng/mL and increased with dose.
• Clearance values varied significantly (32 to 625 mL/kg/min) and showed a negative slope with steady-state concentration.
• Analysis indicated that age, weight, and co-infused dopamine did not influence the clearance-concentration relationship.

Conclusions:

• Dobutamine pharmacokinetics in pediatric patients do not conform to a simple linear model.
• The data suggest that age and concurrent dopamine infusion do not affect dobutamine clearance.
• Further investigation into nonlinear pharmacokinetic models for dobutamine is warranted.